Literature DB >> 24723162

Retinal profile: a clinical indicator of severity in dengue fever in a suburban Indian environment.

Rubii Malhotra1, Luxmi Singh2, R K Bundela3, Pragati Garg2, Diva Kant4, Ankit Garg4, B B Lal5.   

Abstract

PURPOSE: To study the retinal changes in subjects suffering from dengue fever and check if these changes can be taken as sufficient indicator of severity and progression of the disease. PATIENTS/
METHODS: A detailed history was recorded of 118 patients on whom ocular examination, including direct ophthalmoscopy, indirect ophthalmoscopy and coloured fundus photography, was performed.
RESULTS: Forty-seven percent of patients were found to have posterior segment abnormalities. Retinal vein dilatation or tortuosity was the most common finding followed by changes in the optic disc (8.4% of patients) and background haemorrhage (6.7% of patients). With increasing severity of thrombocytopenia, the proportion of patients with retinal abnormalities increased. In patients with grade I thrombocytopenia, no fundal abnormality was found. In those with grade II thrombocytopenia, fundal abnormality was found in 13.63% patients, whereas in the grade III category it was 27.90%.
CONCLUSIONS: Severity of thrombocytopenia had a significant association with retinal abnormalities. Occurrence of fundus changes increases with an increase in severity of thrombocytopenia. Fundus changes were found in all patients with grade IV thrombocytopenia.
© The Author(s) 2014 Reprints and permissions: sagepub.co.uk/journalsPermissions.nav.

Entities:  

Keywords:  Dengue; retinal abnormalities; thrombocytopenia; viral

Mesh:

Substances:

Year:  2014        PMID: 24723162     DOI: 10.1177/0049475514529759

Source DB:  PubMed          Journal:  Trop Doct        ISSN: 0049-4755            Impact factor:   0.731


  1 in total

1.  Case Report: Foveolitis as an Indicator of Underlying Undiagnosed Dengue Fever.

Authors:  Athul S Puthalath; Ramanuj Samanta; Mahsa Jamil; Gitanjli Sood; Devesh Kumawat; Ajai Agrawal
Journal:  Am J Trop Med Hyg       Date:  2021-01       Impact factor: 3.707

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.